MedTrace Logo

Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients

NCT03611439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-08-02

No results posted yet for this study

Summary

This placebo-controlled, double blind study evaluates the treatment effects of adding a multi-pathway botanical dietary supplement (ReBuilder) to the standard treatment regimens of subjects diagnosed with mild or moderate stage Alzheimer's Disease. The objective of the study is to determine if mild and moderate AD patients exhibit improved or stabilized cognitive function when this supplement is added to maximum tolerated doses of their standard treatments.

Conditions

  • Alzheimer Disease
  • Alzheimer Dementia

Interventions

DIETARY_SUPPLEMENT

ReBuilder

8-component botanical dietary supplement

DIETARY_SUPPLEMENT

Placebo

Inactive Placebo Capsule

Sponsors & Collaborators

  • Genescient Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2015-12-25
Completion
2015-12-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03611439 on ClinicalTrials.gov